GlassScriptPhysician profile
Jessica Fowler
NPI 1992347181
$3,042.46
in general payments reported to CMS, 2019-2025
17 companies · $810 in 2025
The $810 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $56.34 · 2021: $261 · 2022: $301 · 2023: $571 · 2024: $1,043 · 2025: $810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,417 · Education: $7.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,416.99 |
| Education | $7.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $770.61 | 2023-2025 | Miebo, Infuse, Xiidra |
| Tarsus Pharmaceuticals, INC. | $356.54 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $335.82 | 2021-2025 | Cequa |
| Coopervision INC. | $261.92 | 2023-2025 | Onefit Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Oyster Point Pharma, INC. | $240.78 | 2022-2024 | Tyrvaya |
| Alcon Vision LLC | $221.53 | 2022-2025 | Precision7, Total30, Tryptyr |
| Novartis Pharmaceuticals Corporation | $216.98 | 2020-2022 | |
| Johnson & Johnson Vision Care, INC. | $182.41 | 2021-2025 | Acuvue |
| Abbvie INC. | $99.36 | 2022-2025 | |
| Mallinckrodt Hospital Products INC. | $69.05 | 2024-2025 | Acthar |
| Allergan, INC. | $64.59 | 2021-2022 | |
| Kala Pharmaceuticals, INC. | $53.84 | 2021-2022 | |
| Dompe US, INC. | $51.40 | 2024-2025 | Oxervate |
| Eyevance Pharmaceuticals LLC | $46.36 | 2021-2022 | |
| Astellas Pharma US INC | $31.54 | 2024 | Izervay |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $27.12 | 2024 | Vevye |
| Aerie Pharmaceuticals, INC. | $12.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Fowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.